1. Anderson, R. E., Maude, M. B., and Bok, D. (2001). Low docosahexaenoic acid levels in rod outer segment membranes of mice with rds/peripherin and P216L peripherin mutations. Invest. Ophthalmol. Vis. Sci. 42:1715–1720.
2. Anderson, R. E., Maude, M. B., McClellan, M., Matthes, M. T., Yasumura, D., and La Vail, M. M. (2002). Low docosahexaenoic acid levels in rod outer segments of rats with P23H and S334ter rhodopsin mutations. Mol. Vis. 8:351–358.
3. Anthonsen, M. W., Solhaug, A., and Johansen, B. (2001). Functional coupling between secretory and cytosolic phospholipase A2 modulates tumor necrosis factor-alpha- and interleukin-1beta-induced NF-kappa B activation. J. Biol. Chem. 276:30527–30536.
4. Barone, F. C., and Feuerstein, G. Z. (1999). Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19:819–834.
5. Basu, A., Krady, J. K., and Levison, S. W. (2004). Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 78:151–156.